Filter
4492
Filtered Results: 4492
Text search:
drug
therapy
Featured
Recommendations
413
New Publications
1118
Language
Document type
No document type
2754
Studies & Reports
639
Guidelines
622
Manuals
183
Strategic & Response Plan
109
Fact sheets
74
Training Material
57
Situation Updates
18
Infographics
14
Resource Platforms
11
Brochures
8
Online Courses
2
App
1
Countries / Regions
India
292
Global
139
Kenya
124
South Africa
117
Uganda
99
Ethiopia
95
Western and Central Europe
94
Nigeria
84
Tanzania
83
Nepal
77
Zambia
76
Sierra Leone
62
Malawi
62
Africa
62
Eastern Europe
58
Latin America and the Carribbean
57
Ghana
55
Ukraine
53
Liberia
53
Rwanda
51
Myanmar / Burma
51
Namibia
50
Bangladesh
42
Zimbabwe
37
Asia
37
Russia
37
Indonesia
35
Lesotho
33
Philippines
31
Cambodia
28
South–East Asia Region
24
Botswana
20
Senegal
19
Germany
17
Syria
16
Eswatini/ Swaziland
16
Burkina Faso
14
Mozambique
14
East and Southern Africa
13
Cameroon
11
Albania
11
USA
11
West and Central Africa
11
Middle East and North Africa
11
Brazil
11
Tajikistan
10
Colombia
10
Haiti
10
Congo, Democratic Republic of
10
South Sudan
10
Eastern Europe and Central Asia
9
Thailand
8
Venezuela
8
China
7
Sudan
7
Pakistan
7
Benin
6
Western Pacific Region
6
Argentina
6
Vietnam
6
Georgia
6
Afghanistan
5
Peru
5
Armenia
5
Iraq
5
North Macedonia
4
Timor Leste/ East Timor
4
Laos
4
Guinea
4
Paraguay
4
United Kingdom
4
Spain
4
Bolivia
4
Moldova
4
Yemen
4
Bhutan
4
Switzerland
3
Estonia
3
Jordan
3
North America
3
Jamaica
3
Sri Lanka
3
Somalia
3
Turkey
2
Kazakhstan
2
Iran
2
Canada
2
Fiji
2
Kyrgyzstan
2
Saudi Arabia
2
Gabon
2
Lebanon
2
Papua New Guinea
2
Central African Republic
2
Poland
2
Mali
2
Angola
2
Chad
2
North Korea
1
Mexico
1
Serbia
1
Australia
1
Gambia
1
Chile
1
Singapore
1
Uzbekistan
1
Malaysia
1
Austria
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Hungary
1
Lithuania
1
Ireland
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
Belarus
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Romania
1
Greece
1
Palestine
1
Libya
1
Ecuador
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1705
Clinical Guidelines
461
Public Health
202
Women & Child Health
149
Key Resources
91
Capacity Building
67
Pharmacy & Technologies
53
Toolboxes
HIV
651
TB
491
Mental Health
444
AMR
226
NTDs
176
Pharmacy
150
COVID-19
149
NCDs
107
Caregiver
80
Malaria
69
Ebola & Marburg
56
Refugee
45
Disability
41
Conflict
41
Rapid Response
39
Planetary Health
28
Global Health Education
28
Health Financing Toolbox
20
Polio
17
Cholera
15
2.0 Rapid Response
13
Specific Hazards
11
Zika
10
Natural Hazards
9
Social Ethics
7
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
Antimicrobial resistance (AMR) and malaria remain significant public health challenges in the WHO Eastern Mediterranean Region (EMR). In 2021, the region reported 1.7 million sepsis-related deaths, with 373,000 associated with bacterial AMR. High antibiotic consumption, particularly in high-income c...
Non-communicable diseases (NCDs) pose a substantial threat to many health systems, especially in low-income and middle-income countries (LMICs) where they are already overstretched. In the past few decades, deaths from NCDs in LMICs have spiked, whereas numbers in high-income countries have stabilis...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Malaria and HIV, two of the world’s most deadly diseases, are widespread, but their distribution overlaps greatly in sub-Saharan Africa. Consequently, malaria and HIV coinfection (MHC) is common in the region. In this paper, pertinent publications on the prevalence, impact, and treatment strategie...
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.
The Global Programme to Eliminate Lymphatic Filariasis (LF) is using mass drug administration (MDA) of antifilarial medications to treat filarial infections, prevent disease and interrupt transmission. Almost 500 million people receive these medications each year. Clinical trials have recently shown...
This concept note describes the methods used to assess the prevalence of any HIVDR and HIVDR by PMTCT exposure among children less than 18 months of age using remnant dried blood spot specimens from early infant diagnosis over a 12-month period
International Journal of Drug Policy 24 (2013) e91-98
Regulation of the Minister of Health of the Republic of Indonesia concerning guidelines for implementation of opioid replacement therapy program
Decree of the Minister of Health of the Republic of Indonesia on the Establishment of Hospitals and Satellite Test of Methadone Therapy Service and Program Guidelines for Methadone Maintenance Therapy
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
Patienteninformation „Sichere Arzneimitteltherapie“ – Arabische Übersetzung. Broschüre auch erhältlich in: Deutsch, Englisch, Französisch, Russisch, Türkisch, Spanisch.
Patient information "Safe Medical Therapy " - Arabic translation. Brochure also available in: German, English, French,...
In the face of rapid increases in the number of hospitalizations due to COVID-19 in Latin America and the Caribbean, coupled with shortages of human and material resources, including medical equipment and gases, there is a need to redesign models of care in the Region to optimize available resources...
Bulletin of the World Health Organization, 2001, 79 (4)
Cardiovascular diseases (CVD) represent the highest burden of disease globally. Medicines are a critical intervention used to prevent and treat CVD. This review describes access to medication for CVD from a health system perspective and strategies that have been used to promote access, including pro...
The article "Can we prevent cardiovascular diseases in low- and middle-income countries?" by Claude Lenfant discusses the growing threat of cardiovascular diseases (CVDs) in developing countries. It highlights that while CVD is already the leading cause of death globally, low- and middle-income coun...
